Diabetic Nephropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meets diagnostic criteria for type 2 diabetes mellitus; (2) Meets diagnostic criteria for diabetic kidney disease stage A2; (3) Traditional Chinese medicine (TCM) differential diagnosis: deficiency of both qi and yin (with blood stasis); (4) HbA1c = 8.5%; (5) eGFR = 60 mL/min/1.73m²; (6) Aged 18 to 75 years, gender unrestricted; (7) Signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe cardiovascular, cerebrovascular, liver, or hematopoietic system diseases; (2) Serum potassium =4.8 mmol/L; (3) Patients on triple antihypertensive therapy with systolic blood pressure =160 mmHg; (4) Pregnant or breastfeeding women; (5) Kidney diseases caused by other reasons; (6) Individuals allergic to the study drug; (7) Individuals who have participated in or are currently participating in clinical trials of other drugs, or are receiving hormonal drugs or immunosuppressive therapy within the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary Albumin-Creatinine Ratio;Glomerular filtration rate;Serum Creatinine;Urea nitrogen;TCM Syndrome Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Glucose;glycated hemoglobin;Cholesterol;Triglyceride;Low-density lipoprotein cholesterol; | — |
Countries
China
Contacts
Integrated Chinese and Western Medicine Hospital, Cangzhou, Province of Hebei